Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

H. Lundbeck A/S

http://www.lundbeck.com

Latest From H. Lundbeck A/S

Kyowa Kirin’s Parkinson’s Successor Shows Phase IIb Promise

Positive clinical results pave path forward for Japanese firm’s potential istradefylline successor.

Clinical Trials Research & Development

Conducting Clinical Trials With CROs: Three Common Risks

Clinical trial sponsors can obtain valuable support from contract research organizations (CROs) but nonetheless remain liable for the conduct of their trials. Sidley Austin partner Dorothee Schramm and senior associate Katie von der Weid, both specialized in international commercial disputes, share tips to protect against common problems that can arise during the course of clinical trials.

Business Strategies Clinical Trials

Gene Editing In China: EdiGene Raises Fresh Funds, Aims For First IND

With gene editing making the news again after the recent Nobel Prize for CRISPR, China’s EdiGene has been raising new funds to accelerate its pipeline to the clinic, led by a potential one-time cure for thalassemia and helped by recent regulatory changes.

China Gene Therapy

Industry Urges Medicare Rethink On 505(b)(2) Policy

Teva, Sun and the AAM are among those urging the CMS to rescind its proposal to reimburse Part B drugs approved under section 505(b)(2) as multiple source products. The proposal would target one relatively small but growing part of Medicare Rx spending and reflects CMS’ ongoing concern with fast rising costs in the program.

Value-Added Medicines Reimbursement
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Abide Therapeutics Inc.
    • Alder Biopharmaceuticals, Inc.
    • Chelsea Therapeutics International, Ltd.
    • Lundbeck La Jolla Research Center
    • Lundbeck Seattle Biopharmaceuticals
    • Ovation Pharmaceuticals, Inc
    • Saegis Pharmaceuticals, Inc.
UsernamePublicRestriction

Register